Literature DB >> 7515388

A change in the isoforms of human chorionic gonadotropin occurs around the 13th week of gestation.

L Wide1, J Y Lee, C Rasmussen.   

Abstract

hCG exhibits a considerable heterogeneity in blood during pregnancy. The overall charge of the isoforms of hCG has been shown to be more negative in the early than in the latter part of pregnancy. The present study analyzes the change in median charge and the charge heterogeneity as pregnancy progresses. The hCG activity in sera from 76 women from weeks 6-43 of gestation was measured with a noncompetitive time-resolved sandwich fluoroimmunoassay. The median charge and degree of charge heterogeneity of the isoforms of hCG in each serum was determined by electrophoresis in 0.10% agarose suspension. Median charge was expressed as median electrophoretic mobility. Electrophoresis with a high resolution revealed that the number of isoforms of hCG in a serum specimen from week 36 of gestation was 20-30. A change in median charge was found to occur at a limited time period of gestation, around the 13th week. All 16 sera from weeks 6-10 had isoforms of hCG with a more negative median charge than that of hCG in 21 sera from weeks 16-43 of gestation. The change in charge was accompanied by an increased degree of charge heterogeneity. There was a significant (P < 0.01) correlation between median mobility and the concentration of hCG during weeks 11-15 of gestation, but not before or after this period. There was no relationship between the sex of the fetus and the median charge of the isoforms of hCG. The data show that a change in the isoforms of hCG, revealed by a change in median charge of hCG, occurs at a limited time around the 13th week of gestation. This change occurs when the hCG concentration in blood decreases, and the placental production of estradiol and progesterone rapidly increases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515388     DOI: 10.1210/jcem.78.6.7515388

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma.

Authors:  M M Elliott; A Kardana; J W Lustbader; L A Cole
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

2.  Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance.

Authors:  Lisa S Kelly; Steven Birken; David Puett
Journal:  Mol Cell Endocrinol       Date:  2006-11-01       Impact factor: 4.102

3.  Clinical effectiveness of urinary human chorionic gonadotropin related protein (hCGRP) quantification for diagnosis of ectopic pregnancy.

Authors:  Jae-Kwan Lee; Min-Jeong Oh; Joong-Sik Shin; Kyung-Joo Lee; Jung-Hyun Nam; Jung-Hak Cha; Jin-Dong Chang; Dong-Hee Cho; In-Soo Kang; Paul I Lee
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 4.  Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms.

Authors:  Veronica Sarais; Greta Chiara Cermisoni; Matteo Schimberni; Alessandra Alteri; Enrico Papaleo; Edgardo Somigliana; Paola Vigano'
Journal:  Int J Mol Sci       Date:  2017-09-20       Impact factor: 5.923

Review 5.  Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles.

Authors:  Janet Choi; Johan Smitz
Journal:  Gynecol Endocrinol       Date:  2013-11-27       Impact factor: 2.260

6.  Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop.

Authors:  P Berger; E Paus; P M Hemken; C Sturgeon; W W Stewart; J P Skinner; L C Harwick; S C Saldana; C S Ramsay; K R Rupprecht; K H Olsen; J-M Bidart; U-H Stenman
Journal:  Tumour Biol       Date:  2013-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.